keyword
https://read.qxmd.com/read/38461632/distinct-disease-modifying-therapies-are-associated-with-different-blood-immune-cell-profiles-in-people-with-relapsing-remitting-multiple-sclerosis
#21
JOURNAL ARTICLE
João Canto-Gomes, Daniela Boleixa, Catarina Teixeira, Ana Martins da Silva, Inés González-Suárez, João Cerqueira, Margarida Correia-Neves, Claudia Nobrega
Disease modifying therapies (DMTs) used for treating people with relapsing-remitting multiple sclerosis (pwRRMS) target the immune system by different mechanisms of action. However, there is a lack of a comprehensive assessment of their effects on the immune system in comparison to treatment-naïve pwRRMS. Herein, we evaluated the numbers of circulating B cells, CD4+ and CD8+ T cells, regulatory T cells (Tregs), natural killer (NK) cells and NKT cells, and their subsets, in pwRRMS who were treatment-naïve or treated with different DMTs...
March 9, 2024: International Immunopharmacology
https://read.qxmd.com/read/38459716/iatrogenic-myelodysplastic-syndrome-complicating-multiple-sclerosis-a-case-report
#22
JOURNAL ARTICLE
Konrad Kubicki, Dusan Stefoski
After 1.5 years of treatment with dimethyl fumarate (DMF) for multiple sclerosis, preceded 8 years earlier by intravenous (IV) cladribine and 1 year earlier by natalizumab, our patient developed myelodysplastic syndrome (MDS). The initial manifestation was a severe drop in absolute neutrophil and lymphocyte counts. Repeat bone marrow biopsy demonstrated a new unbalanced translocation (between the chromosome 1 long arm and chromosome 7 short arm). This case report, to our knowledge, is the first linking iatrogenic MDS to DMF and cladribine, while also suggesting caution with immunosuppressants in multiple sclerosis patients...
March 8, 2024: Multiple Sclerosis: Clinical and Laboratory Research
https://read.qxmd.com/read/38449051/prospective-study-validating-a-multidimensional-treatment-decision-score-predicting-the-24-month-outcome-in-untreated-patients-with-clinically-isolated-syndrome-and-early-relapsing-remitting-multiple-sclerosis-the-proval-ms-study
#23
JOURNAL ARTICLE
Antonios Bayas, Ulrich Mansmann, Begum Irmak Ön, Verena S Hoffmann, Achim Berthele, Mark Mühlau, Markus C Kowarik, Markus Krumbholz, Makbule Senel, Verena Steuerwald, Markus Naumann, Julia Hartberger, Martin Kerschensteiner, Eva Oswald, Christoph Ruschil, Ulf Ziemann, Hayrettin Tumani, Ioannis Vardakas, Fady Albashiti, Frank Kramer, Iñaki Soto-Rey, Helmut Spengler, Gerhard Mayer, Hans Armin Kestler, Oliver Kohlbacher, Marlien Hagedorn, Martin Boeker, Klaus Kuhn, Stefan Buchka, Florian Kohlmayer, Jan S Kirschke, Lars Behrens, Hanna Zimmermann, Benjamin Bender, Nico Sollmann, Joachim Havla, Bernhard Hemmer
INTRODUCTION: In Multiple Sclerosis (MS), patients´ characteristics and (bio)markers that reliably predict the individual disease prognosis at disease onset are lacking. Cohort studies allow a close follow-up of MS histories and a thorough phenotyping of patients. Therefore, a multicenter cohort study was initiated to implement a wide spectrum of data and (bio)markers in newly diagnosed patients. METHODS: ProVal-MS (Prospective study to validate a multidimensional decision score that predicts treatment outcome at 24 months in untreated patients with clinically isolated syndrome or early Relapsing-Remitting-MS) is a prospective cohort study in patients with clinically isolated syndrome (CIS) or Relapsing-Remitting (RR)-MS (McDonald 2017 criteria), diagnosed within the last two years, conducted at five academic centers in Southern Germany...
March 7, 2024: Neurological research and practice
https://read.qxmd.com/read/38437197/psychometric-evaluation-of-the-5-item-medication-adherence-report-scale-questionnaire-in-persons-with-multiple-sclerosis
#24
JOURNAL ARTICLE
Maj Jožef, Igor Locatelli, Gregor Brecl Jakob, Lina Savšek, Katarina Šurlan Popovič, Žiga Špiclin, Uroš Rot, Mitja Kos
The 5-item Medication Adherence Report Scale (MARS-5) is a reliable and valid questionnaire for evaluating adherence in patients with asthma, hypertension, and diabetes. Validity has not been determined in multiple sclerosis (MS). We aimed to establish criterion validity and reliability of the MARS-5 in persons with MS (PwMS). Our prospective study included PwMS on dimethyl fumarate (DMF). PwMS self-completed the MARS-5 on the same day before baseline and follow-up brain magnetic resonance imaging (MRI) 3 and 9 months after treatment initiation and were graded as highly and medium adherent upon the 24-cut-off score, established by receiver operator curve analysis...
2024: PloS One
https://read.qxmd.com/read/38434464/frequency-of-dimethyl-fumarate-induced-lymphopenia-among-omani-patients-with-multiple-sclerosis
#25
JOURNAL ARTICLE
Ahmed Jaboob, Abdullah Al Asmi, M Mazharul Islam, Syed Rezvi, Iman Redha, Jaber Al-Khabouri, Ibrahim Al-Zakwani, Ahmed Al-Qassabi, Haifa Al-Abri, Arunodaya R Gujjar
OBJECTIVES: Dimethyl fumarate (DMF) is known to cause lymphopenia when used to treat patients with multiple sclerosis (MS). However, research on DMF therapy in the Arab world, especially in Oman, is scarce. This study aimed to analyse the prevalence of lymphopenia among Omani patients with MS and their reasons for discontinuing DMF therapy. METHODS: In this retrospective study, the medical records of Omani patients with MS who were treated using DMF at two tertiary hospitals in Muscat, Oman, from February 2017 to February 2023 were reviewed...
February 2024: Sultan Qaboos University Medical Journal
https://read.qxmd.com/read/38434405/knowledge-domain-and-trend-of-disease-modifying-therapies-for-multiple-sclerosis-a-study-based-on-citespace
#26
REVIEW
Ting Zheng, Taotao Jiang, Zilong Huang, Manxia Wang
OBJECTIVE: To explore the current status and trends of disease-modifying therapies (DMTs) for multiple sclerosis through bibliometric and visual analyses of the related literature. METHODS: Relevant literature from the Web of Science Core Collection from 2017 to 2022 was retrieved, and a bibliometric analysis was performed using CiteSpace 6.1. R2. Thesoftware was used to generate visual graphs of the author, institution, country, keyword co-occurrence, and literature co-citation network...
March 15, 2024: Heliyon
https://read.qxmd.com/read/38430538/remodeling-of-the-intra-conduit-inflammatory-microenvironment-to-improve-peripheral-nerve-regeneration-with-a-neuromechanical-matching-protein-based-conduit
#27
JOURNAL ARTICLE
Jia-Yi Wang, Ya Yuan, Shu-Yan Zhang, Shun-Yi Lu, Guan-Jie Han, Meng-Xuan Bian, Lei Huang, De-Hua Meng, Di-Han Su, Lan Xiao, Yin Xiao, Jian Zhang, Ning-Ji Gong, Li-Bo Jiang
Peripheral nerve injury (PNI) remains a challenging area in regenerative medicine. Nerve guide conduit (NGC) transplantation is a common treatment for PNI, but the prognosis of NGC treatment is unsatisfactory due to 1) neuromechanical unmatching and 2) the intra-conduit inflammatory microenvironment (IME) resulting from Schwann cell pyroptosis and inflammatory-polarized macrophages. A neuromechanically matched NGC composed of regenerated silk fibroin (RSF) loaded with poly(3,4-ethylenedioxythiophene): poly(styrene sulfonate) (P:P) and dimethyl fumarate (DMF) are designed, which exhibits a matched elastic modulus (25...
March 2, 2024: Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
https://read.qxmd.com/read/38430351/diverse-efficacy-of-dimethyl-fumarate-in-alleviating-the-late-streptozotocin-induced-cognitive-impairment-and-neuropathological-features-in-rat
#28
JOURNAL ARTICLE
Irena Majkutewicz, Ewelina Kurowska-Rucińska, Jan Ruciński, Dorota Myślińska, Beata Grembecka, Jagoda Mantej, Katarzyna P Dzik
Our previous study showed that dimethyl fumarate (DMF) treatment performed within three weeks after intracerebroventricular (ICV) injection of streptozotocin (STZ) attenuated spatial memory impairment, hippocampal neurodegeneration, and neuroinflammation in rats. The present study is aimed at verifying the hypothesis that DMF alleviates late effects of STZ (6 months after ICV injection) which reflects advanced stage of the Alzheimer's disease (AD) in human patients. Spatial memory was assessed with Morris water maze (MWM), general brain level of amyloid β (Aβ) and p-tau was measured by western blot, immunofluorescent labelling of active microglia (IBA1), Aβ and p-tau and histological assay of neurodegeneration (Fluoro-Jade C) were performed in hippocampus and cortex...
March 2, 2024: Molecular Neurobiology
https://read.qxmd.com/read/38427255/promises-of-lipid-based-nanocarriers-for-delivery-of-dimethyl-fumarate-to-multiple-sclerosis-brain
#29
JOURNAL ARTICLE
Sreya Subhash, Nishtha Chaurawal, Kaisar Raza
Multiple sclerosis (MS) is a neurodegenerative autoimmune disorder of the central nervous system (CNS) infecting 2.5 million people worldwide. It is the most common nontraumatic neurological impairment in young adults. The blood-brain barrier rupture for multiple sclerosis pathogenesis has two effects: first, during the onset of the immunological attack, and second, for the CNS self-sustained "inside-out" demyelination and neurodegeneration processes. In addition to genetic variations, environmental and lifestyle variables can also significantly increase the risk of developing MS...
2024: Methods in Molecular Biology
https://read.qxmd.com/read/38417117/gasdermin-e-dependent-non-canonical-pyroptosis-promotes-drug-induced-liver-failure-by-promoting-cps1-deisgylation-and-degradation
#30
JOURNAL ARTICLE
Shen-Xi Ouyang, Jia-Hui Zhu, Qi Cao, Jian Liu, Zhen Zhang, Yan Zhang, Jing-Wen Wu, Si-Jia Sun, Jiang-Tao Fu, Yi-Ting Chen, Jie Tong, Yi Liu, Jia-Bao Zhang, Fu-Ming Shen, Dong-Jie Li, Pei Wang
Drug-induced liver injury (DILI) is a significant global health issue that poses high mortality and morbidity risks. One commonly observed cause of DILI is acetaminophen (APAP) overdose. GSDME is an effector protein that induces non-canonical pyroptosis. In this study, the activation of GSDME, but not GSDMD, in the liver tissue of mice and patients with APAP-DILI is reported. Knockout of GSDME, rather than GSDMD, in mice protected them from APAP-DILI. Mice with hepatocyte-specific rescue of GSDME reproduced APAP-induced liver injury...
February 28, 2024: Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
https://read.qxmd.com/read/38414723/long-term-clinical-outcomes-in-patients-with-multiple-sclerosis-who-are-initiating-disease-modifying-therapy-with-natalizumab-compared-with-bracetd-first-line-therapies
#31
JOURNAL ARTICLE
Helmut Butzkueven, Tomas Kalincik, Francesco Patti, Mark Slee, Bianca Weinstock-Guttman, Katherine Buzzard, Olga Skibina, Raed Alroughani, Alexandre Prat, Marc Girard, Dana Horakova, Eva Kubala Havrdova, Anneke Van der Walt, Sara Eichau, Robert Hyde, Nolan Campbell, Karthik Bodhinathan, Tim Spelman
BACKGROUND: Aggressive disease control soon after multiple sclerosis (MS) diagnosis may prevent irreversible neurological damage, and therefore early initiation of a high-efficacy disease-modifying therapy (DMT) is of clinical relevance. OBJECTIVES: Evaluate long-term clinical outcomes in patients with MS who initiated treatment with either natalizumab or a BRACETD therapy (interferon beta, glatiramer acetate, teriflunomide, or dimethyl fumarate). DESIGN: This retrospective analysis utilized data from MSBase to create a matched population allowing comparison of first-line natalizumab to first-line BRACETD...
2024: Therapeutic Advances in Neurological Disorders
https://read.qxmd.com/read/38405353/dimethyl-fumarate-exerts-a-neuroprotective-effect-by-enhancing-mitophagy-via-the-nrf2-bnip3-pink1-axis-in-the-mpp-iodide-induced-parkinson-s-disease-mice-model
#32
JOURNAL ARTICLE
Poojitha Pinjala, Kamatham Pushpa Tryphena, Amrita Kulkarni, Prince Giri Goswami, Dharmendra Kumar Khatri
BACKGROUND: Parkinson's disease (PD) is a progressive neurodegenerative disorder linked to the loss of dopaminergic neurons in the substantia nigra. Mitophagy, mitochondrial selective autophagy, is critical in maintaining mitochondrial and subsequently neuronal homeostasis. Its impairment is strongly implicated in PD and is associated with accelerated neurodegeneration. OBJECTIVE: To study the positive effect of dimethyl fumarate (DMF) on mitophagy via the NRF2/BNIP3/PINK1 axis activation in PD disease models...
2024: JAD Reports
https://read.qxmd.com/read/38383481/dimethyl-fumarate-improves-cognitive-impairment-and-neuroinflammation-in-mice-with-alzheimer-s-disease
#33
JOURNAL ARTICLE
Ting Wang, Akira Sobue, Seiji Watanabe, Okiru Komine, Takaomi C Saido, Takashi Saito, Koji Yamanaka
BACKGROUND: Neuroinflammation substantially contributes to the pathology of Alzheimer's disease (AD), the most common form of dementia. Studies have reported that nuclear factor erythroid 2-related factor 2 (Nrf2) attenuates neuroinflammation in the mouse models of neurodegenerative diseases, however, the detailed mechanism remains unclear. METHODS: The effects of dimethyl fumarate (DMF), a clinically used drug to activate the Nrf2 pathway, on neuroinflammation were analyzed in primary astrocytes and AppNL-G-F (App-KI) mice...
February 21, 2024: Journal of Neuroinflammation
https://read.qxmd.com/read/38382805/rank-rankl-axis-promotes-migration-invasion-and-metastasis-of-osteosarcoma-via-activating-nf-%C3%AE%C2%BAb-pathway
#34
JOURNAL ARTICLE
Tomoya Takeda, Masanobu Tsubaki, Shuji Genno, Kana Tomita, Shozo Nishida
Osteosarcoma (OS) is one of the most prevalent primary bone tumors with a high degree of metastasis and poor prognosis. Epithelial-to-mesenchymal transition (EMT) is a cellular mechanism that contributes to the invasion and metastasis of cancer cells, and OS cells have been reported to exhibit EMT-like characteristics. Our previous studies have shown that the interaction between tumor necrosis factor superfamily member 11 (TNFRSF11A; also known as RANK) and its ligand TNFSF11 (also known as RANKL) promotes the EMT process in breast cancer cells...
March 15, 2024: Experimental Cell Research
https://read.qxmd.com/read/38368281/identification-of-key-neuronal-mechanisms-triggered-by-dimethyl-fumarate-in-sh-sy5y-human-neuroblastoma-cells-through-a-metabolomic-approach
#35
JOURNAL ARTICLE
Ana Margarida Araújo, Sandra I Marques, Paula Guedes de Pinho, Helena Carmo, Félix Carvalho, João Pedro Silva
Dimethyl fumarate (DMF) is an old drug used for psoriasis treatment that has recently been repurposed to treat relapse-remitting multiple sclerosis, mostly due to its neuro- and immunomodulatory actions. However, mining of a pharmacovigilance database recently ranked DMF as the second pharmaceutical most associated with cognitive adverse events. To our best knowledge, the signaling mechanisms underlying its therapeutic and neurotoxic outcomes remain mostly undisclosed. This work thus represents the first-hand assessment of DMF-induced metabolic changes in undifferentiated SH-SY5Y human neuroblastoma cells, through an untargeted metabolomic approach using gas chromatography-mass spectrometry (GC-MS)...
February 18, 2024: Archives of Toxicology
https://read.qxmd.com/read/38364937/dimethyl-fumarate-restores-ca-2-dyshomeostasis-through-activation-of-the-sirt1-signal-to-treat-nonalcoholic-fatty-liver-disease
#36
JOURNAL ARTICLE
Rui Zhang, Quanwei Zhang, ZiYi Cui, BenZeng Huang, Haitian Ma
Nonalcoholic fatty liver disease (NAFLD) is characterized by an excessive lipid accumulation in the liver, with a global prevalence of approximately 25 %. While early-stage steatosis is reversible and can be intervened upon, it has the potential to progress to some serious complications, including cirrhosis and even liver cancer. Dimethyl fumarate (DMF), a derivative of fumaric acid shows promise in intervening in certain diseases. However, the precise effect and underlying mechanism of DMF on hepatic steatosis remain unclear...
February 14, 2024: Life Sciences
https://read.qxmd.com/read/38350966/nrf2-activation-rescues-stress-induced-depression-like-behaviour-and-inflammatory-responses-in-male-but-not-female-rats
#37
JOURNAL ARTICLE
Ryan T McCallum, Rachel-Karson Thériault, Joshua D Manduca, Isaac S B Russell, Angel M Culmer, Janan Shoja Doost, Tami A Martino, Melissa L Perreault
BACKGROUND: Major depressive disorder (MDD) is a recurring affective disorder that is two times more prevalent in females than males. Evidence supports immune system dysfunction as a major contributing factor to MDD, notably in a sexually dimorphic manner. Nuclear factor erythroid 2-related factor 2 (Nrf2), a regulator of antioxidant signalling during inflammation, is dysregulated in many chronic inflammatory disorders; however, its role in depression and the associated sex differences have yet to be explored...
February 13, 2024: Biology of Sex Differences
https://read.qxmd.com/read/38348708/nrf2-activation-by-hydroxytyrosol-and-dimethyl-fumarate-ameliorates-skin-tissue-repair-in-high-fat-diet-fed-mice-by-promoting-m2-macrophage-polarization-and-normalizing-inflammatory-response-and-oxidative-damage
#38
JOURNAL ARTICLE
Regina Viana de Carvalho Faria, Matheus Silva Duarte, Jeane de Souza Nogueira, Bianca Martins Gregório, Bruna Romana-Souza
Hydroxytyrosol (HT) or dimethyl fumarate (DMF), activators of nuclear factor erythroid 2-related factor 2 (Nrf2), may reduce obesity in high-fat diet (HFD)-fed animals; nevertheless, the role of these activators on skin tissue repair of HFD-fed animals was not reported. This study investigated whether HT or DMF could improve skin wound healing of HFD-fed obese animals. Mice were fed with an HFD, treated with HT or DMF, and full-thickness skin wounds were created. Macrophages isolated from control and obese animals were treated in vitro with HT...
February 2024: Journal of Biochemical and Molecular Toxicology
https://read.qxmd.com/read/38346199/monkeypox-virus-infection-of-human-astrocytes-causes-gasdermin-b-cleavage-and-pyroptosis
#39
JOURNAL ARTICLE
Hajar Miranzadeh Mahabadi, Y C James Lin, Natacha S Ogando, Eman W Moussa, Nazanin Mohammadzadeh, Oliver Julien, Neal M Alto, Ryan S Noyce, David H Evans, Christopher Power
Monkeypox virus (MPXV) infections in humans cause neurological disorders while studies of MPXV-infected animals indicate that the virus penetrates the brain. Pyroptosis is an inflammatory type of regulated cell death, resulting from plasma membrane rupture (PMR) due to oligomerization of cleaved gasdermins to cause membrane pore formation. Herein, we investigated the human neural cell tropism of MPXV compared to another orthopoxvirus, vaccinia virus (VACV), as well as its effects on immune responses and cell death...
February 20, 2024: Proceedings of the National Academy of Sciences of the United States of America
https://read.qxmd.com/read/38338344/2-5-di-tert-butyl-2-5-diethylpyrrolidine-1-oxyls-where-is-a-reasonable-limit-of-sterical-loading-for-higher-resistance-to-reduction
#40
JOURNAL ARTICLE
Irina F Zhurko, Sergey A Dobrynin, Yurii I Glazachev, Yuri V Gatilov, Igor A Kirilyuk
The pyrrolidine nitroxides with four bulky alkyl substituents adjacent to the N-O∙ group demonstrate very high resistance to reduction with biogenic antioxidants and enzymatic systems. This makes them valuable molecular tools for studying the structure and functions of biomolecules directly in a living cell and for functional EPR and NMR tomography in vivo. The first example of highly strained pyrrolidine nitroxides with both ethyl and tert -butyl groups at each of the α-carbon atoms of the nitroxide moiety with cis -configuration of the tert -butyl groups was prepared using a three-component domino reaction of tert -leucine and 2,2-dimethylpentan-3-one with dimethyl fumarate with subsequent conversion of the resulting strained pyrrolidine into 1-pyrroline-1-oxide and addition of EtLi...
January 25, 2024: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
keyword
keyword
53593
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.